Accumulation of P(T/S)AP late domain duplications in HIV type 1 subtypes B, C, and F derived from individuals failing ARV therapy and ARV drug-naive patients

AIDS Research and Human Retroviruses

Volumn 27, Issue 6, 2011, Pages 687-692

  Martins, Angélica N ^a   Arruda, Mônica B ^a   Pires, Ana F ^a   Tanuri, Amilcar ^a   Brindeiro, Rodrigo M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIVIRAL RESISTANCE; ARTICLE; GENE DUPLICATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE B; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE C; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE F; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS; TREATMENT FAILURE; VIRUS ISOLATION;

AMINO ACID MOTIFS; ANTI-RETROVIRAL AGENTS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA; TREATMENT FAILURE;

EID: 79957593407     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2010.0282     Document Type: Article

References (14)

1. Freed EO: HIV-1 gag proteins: Diverse functions in the virus life cycle. Virology 1998;251(1):1-15 (Pubitemid 28527713)
2. Morita E and Sundquist WI: Retrovirus budding. Annu Rev Cell Dev Biol 2004;20:395-425 (Pubitemid 39488644)
3. Demirov DG and Freed EO: Retrovirus budding. Virus Res 2004;106(2):87-102 (Pubitemid 39582739)
4. Bieniasz PD: Late budding domains and host proteins in enveloped virus release. Virology 2006;344(1):55-63 (Pubitemid 41814450)
5. Fujii K, Hurley JH, and Freed EO: Beyond Tsg101: The role of Alix in 'ESCRTing' HIV-1 Nat Rev Microbiol 2007; 5(12):912-916 (Pubitemid 350131179)
6. Ibe S, Shibata N, Utsumi M, and Kaneda T: Selection of human immunodeficiency virus type 1 variants with an insertion mutation in the p6(gag) and p6(pol) genes under highly active antiretroviral therapy. Microbiol Immunol 2003;47:71-79 (Pubitemid 36119654)
7. Gallego O, de Mendoza C, Corral A, and Soriano V: Changes in the human immunodeficiency virus p7-p1-p6gag gene in drug- naive and pretreated patients. J Clin Microbiol 2003;41:1245-1247 (Pubitemid 36307135)
8. Peters S, Munoz M, Yerly S, Sanchez-Merino V, Lopez- Galindez C, Perrin L, Larder B, Cmarko D, Fakan S, Meylan P, and Telenti A: Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency vírus type 1 p6 protein. J Virol 2001;75(20):9644-9653 (Pubitemid 32900099)
9. Brumme ZL, Chan KJ, Dong WWY, Wynhoven B, Mo T, Hogg RS, Montaner JSG, O'Shaughnessy MV, and Harrigan PR: Prevalence and clinical implications of insertions in the p6Gag N-terminal region in drug-naive individuals initiating antiretroviral therapy. Antiviral Ther 2003;8:91-96 (Pubitemid 36565888)
10. Lastere S, Dalban C, Collin G, Descamps D, Girard PM, Clavel F, Costagliola D, Brun-Vezinet F, and the NARVAL Trial Group (ANRS 088): Impact of insertions in the HIV-1 p6 PTAPP region on the virological response to amprenavir. Antiviral Ther 2004;9(2):221-227 (Pubitemid 38560215)
11. Bates M, Chappey C, Bates S, Limoli K, Wrin T, and Parkin N: Modulation of replication capacity in drug sensitive clade B HIV-1 by protease and the C-terminal end of Gag. Antiviral Ther 2003;8:S81
12. de Oliveira T, Deforche K, Cassol S, Salminem M, Paraskevis D, Seebregts C, Snoeck J, van Rensburg EJ, Wensing AMJ, van de Vijver DA, Boucher CA, Camacho R, and Vandamme A-M: An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinfomatics 2005; 21(19):3797-3800 (Pubitemid 41535530)
13. Gupta RK, Kohli A, McCormick AL, Towers GJ, Pillay D, and Parry CM: Full-length HIV-1 Gag determines protease inhibitor susceptibility within in vitro assays. AIDS 2010;7; 24(11):1651-1655
14. Cao J, McNevin J, McSweyn M, Liu Y, Mullins JI, and McElrath MJ: Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistance. J Virol 2008;82(1):495-502 (Pubitemid 350309163)